US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

Achieve Life Sciences Inc

us-stock
To Invest in {{usstockname}}
us-stock
$4.9 0.0725(7.25%) ACHV at 04 Dec 2025 04:25 PM Biotechnology
Lowest Today 4.54
Highest Today 4.91
Today’s Open 4.54
Prev. Close 4.55
52 Week High 5.78
52 Week Low 1.84
Day’s Range: Low 4.54 High 4.91
52-Week Range: Low 1.84 High 5.78
1 day return -
1 Week return -0.71
1 month return +1.14
3 month return +73.83
6 month return +26.96
1 year return +6.82
3 year return +85.11
5 year return -33.47
10 year return -

Institutional Holdings

Propel Bio Management LLC 12.04

Franklin Resources Inc 8.73

Alyeska Investment Group, L.P. 6.86

Franklin Biotechnology Discv A(acc)USD 5.60

Vanguard Group Inc 4.21

Franklin Biotechnology Discovery A 3.12

Vanguard Total Stock Mkt Idx Inv 2.91

Clearline Capital LP 2.60

Simplify Asset Management Inc. 2.32

Simplify Propel Opportunities ETF 2.32

Hudson Bay Capital Management LP 2.30

Heights Capital Management Inc 1.94

Nantahala Capital Management, LLC 1.76

Vanguard Institutional Extnd Mkt Idx Tr 0.79

Millennium Management LLC 0.76

Geode Capital Management, LLC 0.71

Stonepine Capital Management Llc 0.65

BlackRock Inc 0.62

Shay Capital LLC 0.57

LPL Financial Corp 0.50

Long Focus Capital Management, LLC 0.49

Northern Trust Corp 0.42

Fidelity Extended Market Index 0.35

State Street Corp 0.31

Highbridge Capital Management, LLC 0.26

Royal Bank of Canada 0.23

Extended Equity Market Fund K 0.14

iShares Micro-Cap ETF 0.12

Fidelity Total Market Index 0.12

NT Ext Equity Mkt Idx Fd - NL 0.10

Fidelity Series Total Market Index 0.09

Spartan Extended Market Index Pool F 0.08

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.08

Northern Trust Extended Eq Market Idx 0.07

NT Ext Equity Mkt Idx Fd - L 0.07

Vanguard Balanced Index Inv 0.06

Northern Small Cap Core I 0.06

Spartan Total Market Index Pool G 0.04

Fidelity Nasdaq Composite Index 0.04

Vanguard Instl Ttl Stck Mkt Idx Tr 0.03

Market Status

Strong Buy: 7

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 242.21 M

PB Ratio 7.356

PE Ratio 0.0

Enterprise Value 209.38 M

Total Assets 38.63 M

Volume 746174

Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-35571000 -35.6M, FY22:-41875000 -41.9M, FY21:-32902000 -32.9M, FY20:-14661000 -14.7M, FY19:-16141000 -16.1M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:-55000 -0.1M, Q1/2025:-62000 -0.1M, Q3/2024:null 0.0M, Q2/2024:-57000 -0.1M

Quarterly Net worth Q3/2025:-14441000 -14.4M, Q2/2025:-12718000 -12.7M, Q1/2025:-12827000 -12.8M, Q3/2024:-12512000 -12.5M, Q2/2024:-8461000 -8.5M

Fund house & investment objective

Company Information Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.

Organisation Biotechnology

Employees 25

Industry Biotechnology

CEO Dr. Richard A. B. Stewart

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right